HHS

ACA Benefit Parameters and Basic Health Program Correction Proposed Rule

The Department of Health and Human Services (HHS) is issuing a correction to a proposed rule concerning the Affordable Care Act (ACA) benefit parameters and the Basic Health Program. This correction addresses technical errors, specifically the omission of column headings in several tables within the original proposed rule published on February 11, 2026.

HHS Drug Testing Panel Guidelines

The Department of Health and Human Services (HHS) has issued updated guidelines for authorized drug testing panels used in federal workplace drug testing programs. The current drug testing panels for urine and oral fluid, along with the required nomenclature for laboratory and Medical Review Officer Reports, remain in effect as of July 7, 2025, with minor edits to footnotes for clarity.

HHS Proposes Rescinding LGBTQI+ Children Placement Rule

The Administration for Children and Families (ACF) proposes to remove a final rule concerning designated placement requirements for LGBTQI+ children in foster care. This action follows a court decision vacating the rule, which the court found exceeded HHS's statutory authority. The public comment period for this proposed rescission ends April 6, 2026.

HHS Opioid Use Disorder Medications Correction

The Department of Health and Human Services (HHS) is issuing a correcting amendment to the final rule on Medications for the Treatment of Opioid Use Disorder. This document corrects outdated references within the regulation, with an effective date of February 23, 2026.

HHS Modifies Privacy Act System of Records

The Department of Health and Human Services (HHS) is modifying a Privacy Act system of records, System No. 09-90-0052, to include reporting on substance use disorder patient records. The comment period for these modifications ends on March 19, 2026.

Center for Scientific Review Notice of Closed Meetings

The National Institutes of Health's Center for Scientific Review has announced upcoming closed meetings. These meetings are scheduled to occur on April 14, 2026. The purpose of these meetings is related to the review of grant applications.

NIH Director's Office Meeting Notice

The National Institutes of Health (NIH) has published a notice announcing an upcoming meeting of the Office of the Director. The notice provides details regarding the meeting, which is scheduled for April 13, 2026. This is an informational announcement regarding a government meeting.

Health Workforce Connector Public Comment Request

The Health Resources and Services Administration has submitted a revision to the Health Workforce Connector information collection activity to the Office of Management and Budget (OMB) for review and approval. The public has 32 days to submit comments on this submission.

Center for Scientific Review Closed Meetings Notice

The National Institutes of Health published a notice regarding upcoming closed meetings for the Center for Scientific Review. These meetings are scheduled for April 15, 2026, and will involve discussions that are exempt from public disclosure under specific provisions of the Government in the Sunshine Act.

HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs

The Department of Health and Human Services (HHS) has published updated guidelines for federal workplace drug testing programs. The rule confirms that current authorized drug testing panels and required report nomenclature remain in effect.